Tag
MIT Technology Review's daily newsletter covering a $73M DARPA project to create shelf-stable synthetic blood products, WeLion New Energy's semi-solid-state battery advances, and the FBI's arrest of an OpenAI engineer accused of planting a recording device.
报道了DARPA在慢性血液短缺背景下,投入7300万美元研发合成血液替代品的军事医学项目,旨在解决战场与民用急救中的储血和运输难题。
Palantir's CTO reportedly claimed some AI researchers have taken up smoking, believing future AI will cure cancer. The claim highlights growing public discourse around AI's expected medical breakthroughs.
Rubedo Life Sciences 报告其靶向细胞衰老(senescence)的外用抗衰老乳膏在小型临床试验中让受试者皮肤生物年龄平均降低约两年,并计划扩展至银屑病、脱发及口服制剂开发。
A tech figure (@gabriel1) argues that AI will soon cure most diseases, and warns that slow regulatory approval could cost billions of years of life, urging regulators to staff up and speed up approvals.
PopVax has dosed the first participants in a Phase 1 trial of PVX-001, an open-source broadly protective COVID-19 vaccine built on its own computational protein design, mRNA-VLP, and fridge-stable LNP platform, with the design to be open-sourced after the trial concludes.
一家初创公司在30天内建成8000平方英尺的实验室,用于测试AI提出的分子,目前可在约72小时内测量这些分子在活体生物中的有效率。
A discussion prompt asking whether recent medical and scientific advances have shifted people's expectations about potentially cheating death within their lifetime, and what breakthroughs they see on the horizon.
MIT Technology Review 的每日科技简讯,涵盖 AI 模型拒绝机制的局限与风险、GLP-1 减肥药副作用的最新研究,以及美国冻结微软等 IT 公司的绿卡申请。
A Phase 1 trial reports what may be the first successful rejuvenation of human eye cells, using three Yamanaka factors delivered as proteins to reprogram damaged retinal ganglion cells in glaucoma patients, based on David Sinclair's epigenetic reprogramming theory.
Biohub, the U.S. Department of Energy, the NIH, Google DeepMind, Isomorphic Labs, and Meta jointly committed $1.8 billion to generate AI-ready open biological datasets, the largest coordinated effort to date to enable predictive AI models of biology and a 'virtual cell'.
Theranos.world 是一个无需密码即可登录的沉浸式互动网站,重现 Theranos 办公室场景,并宣传将于 10 月 22 日在旧金山举办的纪录片放映活动。
Biohub, the U.S. Department of Energy, NIH, Google DeepMind, Isomorphic Labs, and Meta announced a $1.8 billion expansion of the Virtual Biology Initiative to generate open, AI-ready biological datasets for building predictive models of biology and accelerating disease research.
Multiply Labs, a YC S16 robotics startup, raised a $75M Series B led by NantWorks to build robots that automate manufacturing of complex drugs like gene therapies and mRNA treatments, with deployments at AstraZeneca and Legend Biotech facilities.
Novo Nordisk and Eli Lilly report that GLP-1 weight-loss drugs such as semaglutide reduce molecular aging-clock markers by roughly two to four years, suggesting these medications may act as geroprotectors that slow biological aging.
YC S21 startup Sensible Biotechnologies raised a $47M Series A to scale its platform for engineering living cells to manufacture mRNA, aiming to meet the higher dose and purity demands of next-generation mRNA medicines like in vivo CAR-T and gene editing.
NASA's SpaceX Crew-12 is concluding its International Space Station mission after conducting microgravity research on cancer-targeting treatments, bone regeneration, cold atoms, and antibiotic-resistant bacteria.
A quote-post highlighting a research note by Freda Duan arguing that AI drug discovery (AIDD) is undergoing a regime change, with frontier AI labs entering the space and making it an increasingly investable theme for the US pharmaceutical sector.
MIT Technology Review's daily newsletter covers an opinion piece by ex-DeepMind researcher Thore Graepel arguing LLMs don't truly reason and proposing AlphaGo-inspired approaches, a biological-age de-aging contest, and OpenAI's report that rogue agents may have affected over 100 organizations.
A six-month contest called Younger, founded by neuroscientist Christin Glorioso of NeuroAge Therapeutics, pits around 500 participants against each other to reverse their biological age as measured by a variety of aging clocks, aiming to build the world's most comprehensive biological age dataset.